Therapeutic targeting of P300/CBP in clear cell renal cell carcinoma
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2110252
- Recipient
-
The Institute For Cancer Research UEI FF1XVJMDYVR1 Part of Temple University-Of The Commonwealth System Of Higher Education
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $187,000
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Originally
- Place of performance
- Philadelphia, PA 19111, USA
Award details come from USAspending.gov.
About this award
The Institute For Cancer Research at Temple University received a $187,000 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The two-year award, which runs from April 1, 2021 through March 31, 2023, will support research into therapeutic targeting of P300/CBP in clear cell renal cell carcinoma. The Military Medical Research and Development program aims to transform military and public health through innovative medical research solutions for service members and the general public. This award furthers those goals by funding investigation into potential medical treatments for clear cell renal cell carcinoma, advancing the program's priority areas of battlefield medicine and public health.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $187,000 |
Quick answers
Who received award W81XWH2110252?
W81XWH2110252 was awarded to The Institute For Cancer Research by Medical Command (Department of the Army) on April 1, 2021.
How much is award W81XWH2110252 worth?
$187,000 has been obligated on W81XWH2110252.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award